Menu Close

Articles on Psychedelic

Displaying all articles

Considering how to reduce the impact of conflicts of interest on psychedelic studies is essential to avoid public health risks. (Shutterstock)

How corporate involvement in psychedelic research could threaten public safety

Substantial economic growth in the psychedelic drugs market has drawn interest from corporations and start-ups. While this may accelerate research, it also sparks concerns about conflicts of interest.
Subcommittee on Veterans Affairs Chair Senator David Richards and Deputy Chair Senator Pierre-Hugues Boisvenu at a news conference releasing the committee’s report on the need for psychedelic-assisted therapy for veterans on Nov. 8, 2023 in Ottawa. THE CANADIAN PRESS/Adrian Wyld

Canada owes its veterans new mental health tools: Access to psychedelic therapies is overdue

One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.
Psilocybin and other psychedelics could help patients process the challenges of a cancer diagnosis. Kateryna Kon/Science Photo Library via Getty Images

Psychedelics may better treat depression and anxiety symptoms than prescription antidepressants for patients with advanced cancer

Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
Psychedelics are being held up as a potential solution to the growing need for mental health treatment. But, magic mushrooms are not magic bullets. (AP Photo/Peter Dejong)

Alberta’s new policy on psychedelic drug treatment for mental illness: Will Canada lead the psychedelic renaissance?

Alberta’s new policy on psychedelic-assisted therapy for mental illness may set a precedent that moves Canadians one step closer to accepting psychedelics as medicinal substances.

Top contributors

More